While low pCXCR4/CXCR4 ratio of tumor expression in recurrent cancer biopsies in patients with high-grade ovarian carcinoma showed a trend that was associated with better RFS (p = 0.042; Fig. 2D). The gene discussed is CXCR4; the disease is cancer.